Parkman Healthcare Partners LLC Landec Corp \Ca\ Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.0 - $9.95 $0 - $13,233
1,330 Added 0.66%
203,578 $0
Q3 2022

Nov 14, 2022
BUY
$8.57 - $11.57 $690,999 - $932,889
80,630 Added 66.3%
202,248 $1.8 Million
Q2 2022

Aug 12, 2022
BUY
$8.84 - $11.64 $55,709 - $73,355
6,302 Added 5.46%
121,618 $1.21 Million
Q1 2022

May 13, 2022
BUY
$10.07 - $11.93 $1.16 Million - $1.38 Million
115,316 New
115,316 $1.34 Million

Others Institutions Holding LNDC

# of Institutions
80
Shares Held
20.4M
Call Options Held
65.8K
Put Options Held
14.1K
View Full List

About LANDEC CORP \CA\

LNDC Quotes by TradingView
  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email